Do you want to read an article? Please log in or register.
Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! Project
Macular Diseases
COMMENTED
Related content
RECOMMENDED
Macular Diseases
Changes in real-world treatment patterns for diabetic macular oedema from 2009-2019 and five-year outcomes: Data from the Fight Retinal Blindness! Registry
★ 1
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
doi: 10.1111/ceo.13781.
RECOMMENDED
Macular Diseases
FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project
★ 2
Recommended by
PD Dr Moreno Menghini, Faculty Member
doi: 10.1097/IAE.0000000000002798.
COMMENTED
Macular DiseasesRetinal Diseases
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
★ 1
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Acta Ophthalmol
Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D
doi: 10.1111/aos.14893
Macular DiseasesRetinal Diseases
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry
Clin Exp Ophthalmol
Nguyen V, Barthelmes D, Gillies MC
doi: 10.1111/ceo.13949
Macular Diseases
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry
Ophthalmology.
Bhandari S, Nguyen V, Arnold J, Young S, Banerjee G, Gillies M, Barthelmes D
doi: 10.1016/j.ophtha.2019.10.006.
Retinal Diseases
Intraocular Pressure Changes and VEGF Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry
Ophthalmol Retina.
Gabrielle PH, Nguyen V, Wolff B, Essex R, Young S, Hunt A, Gemmy Cheung CM, Arnold JJ, Barthelmes D, Creuzot-Garcher C, Gillies M, Fight Retinal Blindness! Study Group.
doi: 10.1016/j.oret.2020.06.020.
Macular Diseases
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry
Graefes Arch Clin Exp Ophthalmol
Figueras-Roca M, Parrado-Carrillo A, Nguyen V, Casaroli-Marano RP, Moll-Udina A, Gillies MC, Barthelmes D, Zarranz-Ventura J
doi: 10.1007/s00417-020-05016-9
Retinal Diseases
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
BMC Ophthalmol.
Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Finger RP, Sakamoto T, Wong TY, Evuarherhe O, Carter G, Carrasco J
doi: 10.1186/s12886-019-1208-9.
RECOMMENDED
Macular Diseases
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry
★ 1
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
doi: 10.1111/ceo.13707.